Eva L. Feldman
Eva L. Feldman
Verified email at - Homepage
Cited by
Cited by
Diabetic neuropathies: a statement by the American Diabetes Association
AJM Boulton, AI Vinik, JC Arezzo, V Bril, EL Feldman, R Freeman, ...
Diabetes care 28 (4), 956-962, 2005
Diabetic neuropathy: a position statement by the American Diabetes Association
R Pop-Busui, AJM Boulton, EL Feldman, V Bril, R Freeman, RA Malik, ...
Diabetes care 40 (1), 136, 2017
A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy
EL Feldman, MJ Stevens, PK Thomas, MB Brown, N Canal, DA Greene
Diabetes care 17 (11), 1281-1289, 1994
Oxidative stress in the pathogenesis of diabetic neuropathy
AM Vincent, JW Russell, P Low, EL Feldman
Endocrine reviews 25 (4), 612-628, 2004
Diabetic neuropathy: clinical manifestations and current treatments
BC Callaghan, HT Cheng, CL Stables, AL Smith, EL Feldman
The lancet NEUROLOGY 11 (6), 521-534, 2012
Diabetic neuropathy
EL Feldman, BC Callaghan, R Pop-Busui, DW Zochodne, DE Wright, ...
Nature reviews Disease primers 5 (1), 1-18, 2019
Diabetic neuropathy: mechanisms to management
JL Edwards, AM Vincent, HT Cheng, EL Feldman
Pharmacology & therapeutics 120 (1), 1-34, 2008
Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic …
V Bril, J England, GM Franklin, M Backonja, J Cohen, D Del Toro, ...
Pm&r 3 (4), 345-352. e21, 2011
New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain
EL Feldman, KA Nave, TS Jensen, DLH Bennett
Neuron 93 (6), 1296-1313, 2017
Enhanced glucose control for preventing and treating diabetic neuropathy
BC Callaghan, AA Little, EL Feldman, RAC Hughes
Cochrane database of systematic reviews, 2012
Lifestyle intervention for pre-diabetic neuropathy
AG Smith, J Russell, EL Feldman, J Goldstein, A Peltier, S Smith, J Hamwi, ...
Diabetes care 29 (6), 1294-1299, 2006
Diabetic neuropathy: cellular mechanisms as therapeutic targets
AM Vincent, BC Callaghan, AL Smith, EL Feldman
Nature Reviews Neurology 7 (10), 573-583, 2011
High glucose‐induced oxidative stress and mitochondrial dysfunction in neurons
JW Russell, D Golovoy, AM Vincent, PIA Mahendru, JA Olzmann, ...
The FASEB Journal 16 (13), 1738-1748, 2002
Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity
PJ Dyck, JW Albers, H Andersen, JC Arezzo, GJ Biessels, V Bril, ...
Diabetes/metabolism research and reviews 27 (7), 620-628, 2011
Genome-wide analyses identify KIF5A as a novel ALS gene
A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ...
Neuron 97 (6), 1268-1283. e6, 2018
The insulin-like growth factor system and its pleiotropic functions in brain
VC Russo, PD Gluckman, EL Feldman, GA Werther
Endocrine reviews 26 (7), 916-943, 2005
Microvascular complications of impaired glucose tolerance
JR Singleton, AG Smith, JW Russell, EL Feldman
Diabetes 52 (12), 2867-2873, 2003
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion
CL Martin, J Albers, WH Herman, P Cleary, B Waberski, DA Greene, ...
Diabetes care 29 (2), 340-344, 2006
How does diabetes accelerate Alzheimer disease pathology?
C Sims-Robinson, B Kim, A Rosko, EL Feldman
Nature Reviews Neurology 6 (10), 551-559, 2010
Complications: neuropathy, pathogenetic considerations
DA Greene, AAF Sima, MJ Stevens, EL Feldman, SA Lattimer
Diabetes care 15 (12), 1902-1925, 1992
The system can't perform the operation now. Try again later.
Articles 1–20